CClinicalTrials.gg
CompletedNCT05826002Updated Mar 12, 2025

Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment

An interventional study of Digital self-guided psychological intervention for insomnia in Insomnia, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-12.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
447
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms. In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms. The participants will be adults with insomnia. The trial will be a 2x2x2 randomized factorial experiment, where the following features/factors will be manipulated: an optimized graphical user interface (yes or no), an adaptive treatment strategy (yes or no), and daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features. The main outcome will be the effect on treatment engagement.

02

Conditions studied

  • Insomnia

Keywords

  • Insomnia
  • ICBT
  • Factorial Experiment
  • Optimization
  • User Interface
  • Adaptive Treatment Strategy
  • Prompts
  • Digital Intervention
03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's enrollment of 447 is above the median of 73 across 1,631 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. ≥ 18 years of age.
  2. ≥ 15 points on Insomnia Severity Index.
  3. Insomnia diagnosis, according to criteria in the Diagnostic and Statistical Manual of mental disorders-5 (somatic/psychiatric comorbidity is allowed).
  4. Good understanding of the Swedish language.
  5. No practical obstacles to participate in treatment and assessments.
  6. Daily access to computer/smart-phone/tablet with Internet access.
  7. Can receive phone calls and text messages during the study period.

Exclusion criteria

Exclusion Criteria:

  1. Sleep diseases, such as narcolepsy or sleep apnea.
  2. Somatic or psychiatric illnesses that either are directly contraindicated for the treatment, require other treatment, or entail symptoms/a functional level making it too difficult to participate in the study.
  3. Alcohol/drug abuse, or medication with side effects on sleep (however, sleep medication is allowed).
  4. Working nights or night shifts.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
447 participants (actual)

Study arms

  • Active comparator
    Digital insomnia intervention

    This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (no).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + optimized user interface

    This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (no).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + adaptive treatment strategy

    This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (no).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + optimized user interface, adaptive treatment strategy

    This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (no).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + daily prompts

    This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (yes).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + optimized user interface, daily prompts

    This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (yes).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + adaptive treatment strategy, daily prompts

    This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (yes).

    Behavioral: Digital self-guided psychological intervention for insomnia

  • Active comparator
    Digital insomnia intervention + optimized user interface, adaptive treatment strategy, daily prompts

    This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (yes).

    Behavioral: Digital self-guided psychological intervention for insomnia

Interventions

  • BehavioralDigital self-guided psychological intervention for insomnia

    A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

06

What researchers measure

Primary outcomes

  1. Engagement with intervention method

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

    Time frame: Up to 12 months after treatment

  2. Engagement with intervention method

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

    Time frame: Immediately after treatment (4 weeks after treatment start)

Secondary outcomes

  1. Change in Insomnia symptoms

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

    Time frame: Change from baseline (right before treatment start) up to 12 months after treatment

  2. Change in Insomnia symptoms

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

    Time frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  3. Change in Depression symptoms

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

    Time frame: Change from baseline (right before treatment start) up to 12 months after treatment

  4. Change in Depression symptoms

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

    Time frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  5. Change in Anxiety symptoms

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

    Time frame: Change from baseline (right before treatment start) up to 12 months after treatment

  6. Change in Anxiety symptoms

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

    Time frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  7. Change in Life quality

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

    Time frame: Change from baseline (right before treatment start) up to 12 months after treatment

  8. Change in Life quality

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

    Time frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  9. Change in Daily function

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

    Time frame: Change from baseline (right before treatment start) up to 12 months after treatment

  10. Change in Daily function

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

    Time frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  11. Treatment credibility

    Credibility/Expectancy Questionnaire (self-rated), score range 0-50, higher is better

    Time frame: 2 weeks after treatment start (mid-treatment)

  12. Intervention/system usability

    System Usability Scale (self-rated), score range 0-100, higher is better

    Time frame: 2 weeks after treatment start (mid-treatment)

  13. Treatment satisfaction

    Client Satisfaction Questionnaire-8 (self-rated), score range 8-32, higher is better

    Time frame: Immediately after treatment (4 weeks after treatment start)

Other outcomes

  1. Clinician time

    Time in minutes the clinician spends on the participant giving guidance through telephone calls and/or written guidance, in minutes, lower is better

    Time frame: Immediately after treatment (4 weeks after treatment start)

07

Study locations

1 site
  • Centre for Psychiatry Research
    Stockholm, Sweden
08

References and documents

Individual participant data

Plan to share: Undecided — IPD available anonymized on reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05826002
Lead sponsor
Karolinska Institutet
Collaborators
Region Stockholm
Responsible party
Martin Kraepelien (Clinical Psychologist, Principal Investigator, PhD, Karolinska Institutet) — Principal investigator
First posted
Apr 24, 2023
Start date
May 1, 2023
Primary completion
Dec 15, 2024
Completion
Dec 15, 2024
Last update
Mar 12, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion